Feasibility and Safety of a Three-Dimensional Sheath for Right Ventricular Septal Endomyocardial Biopsy
- PMID: 40739845
- DOI: 10.1002/ccd.70064
Feasibility and Safety of a Three-Dimensional Sheath for Right Ventricular Septal Endomyocardial Biopsy
Abstract
Background: Endomyocardial biopsy (EMB) is a complementary invasive procedure for the diagnosis of several cardiac diseases. New technical developments are needed to increase the safety of the procedure even in low-volume centers.
Methods: We retrospectively enrolled patients who underwent EMB in our institution, which is a non-heart transplant tertiary care center. Patients were divided into two groups according to the use of a standard long sheath (S-T) or a three-dimensional sheath (3D-T). The latter was originally designed for conduction system pacing.
Results: There were 30 patients in the S-T group and 16 in the 3D-T group. Patients in the 3D-T group were older (65 ± 19 vs. 52 ± 20, p = 0.049) and more likely to have ischaemic heart disease (25% vs. 0%, p = 0.011). Indications for EMB were similar in both groups except for a higher proportion of amyloidosis in the 3D-T group (56% vs. 17%, p = 0.005). The total number of collected samples (10 ± 2 vs. 11 ± 3), their dimensions (1.3 ± 0.6 mm x 1 ± 0.3 mm vs. 1.7 ± 0.6 mm x 1.2 ± 0.4 mm) and the proportion of specimens meeting the quality standard to be analyzed (76% ± 26% vs. 83% ± 25%) didn't differ between 3D-T and S-T (all p = ns). Pericardial effusion or cardiac tamponade was more frequent in the S-T group compared to the 3D-T group (23% vs. 0%, p = 0.078). There were five cardiac tamponades in the S-T group and none in the 3D-T group.
Conclusion: The use of a 3D sheath for EMB of the right ventricular septum was feasible and safe with similar diagnostic accuracy compared to the standard long sheath technique.
© 2025 Wiley Periodicals LLC.
References
-
- O. Leone, J. P. Veinot, A. Angelini, et al., “2011 Consensus Statement on Endomyocardial Biopsy From the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology,” Cardiovascular Pathology 21 (2012): 245–274.
-
- C. Basso, “Ultrastructural Evidence of Intercalated Disc Remodelling in Arrhythmogenic Right Ventricular Cardiomyopathy: An Electron Microscopy Investigation on Endomyocardial Biopsies,” European Heart Journal 27 (August 2006): 1847–1854.
-
- T. Isogai, H. Yasunaga, H. Matsui, et al., “Hospital Volume and Cardiac Complications of Endomyocardial Biopsy: A Retrospective Cohort Study of 9508 Adult Patients Using a Nationwide Inpatient Database in Japan,” Clinical Cardiology 38 (March 2015): 164–170.
-
- C. Chimenti and A. Frustaci, “Contribution and Risks of Left Ventricular Endomyocardial Biopsy in Patients With Cardiomyopathies: A Retrospective Study over a 28‐year Period,” Circulation 128 (October 2013): 1531–1541.
-
- R. Bagur, O. F. Bertrand, P. Béliveau, et al., “Feasibility of Using a Sheathless Guiding Catheter for Left Ventricular Endomyocardial Biopsy Performed by Transradial Approach,” The Journal of Invasive Cardiology 26 (2014): 161–163.
LinkOut - more resources
Full Text Sources
Miscellaneous